Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

190 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status.
Roodakker KR, Elsir T, Edqvist PD, Hägerstrand D, Carlson J, Lysiak M, Henriksson R, Pontén F, Rosell J, Söderkvist P, Stupp R, Tchougounova E, Nistér M, Malmström A, Smits A. Roodakker KR, et al. Among authors: malmstrom a. Oncotarget. 2016 Nov 8;7(45):72431-72442. doi: 10.18632/oncotarget.11957. Oncotarget. 2016. PMID: 27626492 Free PMC article.
Prognostic value of O-6-methylguanine-DNA methyltransferase (MGMT) protein expression in glioblastoma excluding nontumour cells from the analysis.
Dahlrot RH, Dowsett J, Fosmark S, Malmström A, Henriksson R, Boldt H, de Stricker K, Sørensen MD, Poulsen HS, Lysiak M, Söderkvist P, Rosell J, Hansen S, Kristensen BW. Dahlrot RH, et al. Among authors: malmstrom a. Neuropathol Appl Neurobiol. 2018 Feb;44(2):172-184. doi: 10.1111/nan.12415. Epub 2017 Jun 28. Neuropathol Appl Neurobiol. 2018. PMID: 28574607
ABCB1 single-nucleotide variants and survival in patients with glioblastoma treated with radiotherapy concomitant with temozolomide.
Malmström A, Łysiak M, Åkesson L, Jakobsen I, Mudaisi M, Milos P, Hallbeck M, Fomichov V, Broholm H, Grunnet K, Poulsen HS, Bratthäll C, Strandeus M, Papagiannopoulou A, Stenmark-Askmalm M, Green H, Söderkvist P. Malmström A, et al. Pharmacogenomics J. 2020 Apr;20(2):213-219. doi: 10.1038/s41397-019-0107-z. Epub 2019 Oct 17. Pharmacogenomics J. 2020. PMID: 31624332
Assessment of genetic and non-genetic risk factors for venous thromboembolism in glioblastoma - The predictive significance of B blood group.
Heenkenda MK, Malmström A, Lysiak M, Mudaisi M, Bratthäll C, Milos P, Strandeus M, Åkesson L, Söderkvist P, Uppugunduri S, Osman A. Heenkenda MK, et al. Among authors: malmstrom a. Thromb Res. 2019 Nov;183:136-142. doi: 10.1016/j.thromres.2019.10.009. Epub 2019 Oct 22. Thromb Res. 2019. PMID: 31677594 Free article.
Postoperative neoadjuvant temozolomide before radiotherapy versus standard radiotherapy in patients 60 years or younger with anaplastic astrocytoma or glioblastoma: a randomized trial.
Malmström A, Poulsen HS, Grønberg BH, Stragliotto G, Hansen S, Asklund T, Holmlund B, Łysiak M, Dowsett J, Kristensen BW, Söderkvist P, Rosell J, Henriksson R; Nordic Clinical Brain Tumor Study Group (NCBTSG). Malmström A, et al. Acta Oncol. 2017 Dec;56(12):1776-1785. doi: 10.1080/0284186X.2017.1332780. Epub 2017 Jul 4. Acta Oncol. 2017. PMID: 28675067 Clinical Trial.
190 results